Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperaquine induced blood-stage malaria challenge study
ACTRN12613000565741Phase 2Completed
- Sponsor
- QIMR Berghofer Medical Research Institute
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of piperaquine in malaria, sponsored by QIMR Berghofer Medical Research Institute. Primary endpoint: Primary: pharmacokinetic-pharmacodynamic relationship of piperaquine and parasite clearance. Started Jun 2013; status: completed.
02
Drugs
piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on ACTRN12613000565741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000565741.